Target- |
Mechanism- |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment
This research is studying the effect that Resolvine injection will have on patients with vitreomacular adhesion.
100 Clinical Results associated with Kato Pharmaceuticals, Inc.
0 Patents (Medical) associated with Kato Pharmaceuticals, Inc.
100 Deals associated with Kato Pharmaceuticals, Inc.
100 Translational Medicine associated with Kato Pharmaceuticals, Inc.